In Togo, the pregnant women living with hiv antiretroviral therapy coverage for pmtct currently stands at 68%, reflecting an increase of 1% (1.5%) compared to 2020.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Togo
PMTCT antiretroviral therapy coverage
No matching regions
Data currently not available for this time and region, try a different time period
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,545
Measure:
%
What is Togo's PMTCT antiretroviral therapy coverage?
As of 2021 Togo's PMTCT antiretroviral therapy coverage was 68.
How does Togo's PMTCT antiretroviral therapy coverage compare to other regions?
Togo's PMTCT antiretroviral therapy coverage was ranked 51st in 2021
Similar regions to Togo
PMTCT antiretroviral therapy coverage
More indicators for Togo
Togo PMTCT antiretroviral therapy coverage between 2000 and 2021
Period | PMTCT antiretroviral therapy coverage | Change |
---|---|---|
2021 | 68% | 1% |
2020 | 67% | 10% |
2019 | 77% | 1% |
2018 | 76% | 9% |
2017 | 67% | 15% |
2016 | 82% | 6% |
2015 | 76% | 5% |
2014 | 71% | 2% |
2013 | 69% | 3% |
2012 | 66% | 5% |
2011 | 61% | 32% |
2010 | 29% | 9% |
2009 | 20% | 5% |
2008 | 15% | 6% |
2007 | 9% | 1% |
2006 | 8% | 4% |
2005 | 4% | 2% |
2004 | 2% | 1% |
2003 | 1% | 1% |
2002 | 0% | 0% |
2001 | 0% | 0% |
2000 | 0% |
×